3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

The 3D bioprinting market is expected to reach USD 1,332.6 million by 2021, at a CAGR of 26.5% from 2016 to 2021.

The 3D bioprinting market is primarily driven by the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

In this report, the 3D bioprinting market has been segmented on the basis of technology, applications (clinical and research applications), materials (living cells, hydrogels, extracellular matrices, and other biomaterials), and regions (North America, Europe, APAC, and the RoW). By technology, the global 3D bioprinting market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion 3D bioprinting market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the 3D bioprinting market in 2016, followed by Europe. Increasing government initiatives and rising demand for organ transplants are the major factors driving market growth in North America. However, the presence of a stringent regulatory process for the approval of 3D bioprinting products is a major factor restraining the growth of this regional segment.

The 3D bioprinting market consists of a number of big, medium-sized, and small companies. As of 2015, the syringes market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Product launches, development, and commercialization; agreements; collaboration; and partnerships were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the 3D bioprinting market.

Research Coverage
This report studies the 3D bioprinting market based on technology, application, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
This research report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles—which together discuss basic views on the competitive landscape, emerging and high-growth segments of the 3D bioprinting market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on products and services offered by major players in the 3D bioprinting market. The report analyzes the 3D bioprinting market based on technology, application, material, and region

‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the 3D bioprinting market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various 3D bioprinting products across geographies

‧ Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the 3D bioprinting market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the 3D bioprinting market

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 15
1.4 MARKETS COVERED 15
1.5 YEARS CONSIDERED FOR THE STUDY 16
1.6 CURRENCY 16
1.7 LIMITATIONS 16
1.8 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH METHODOLOGY STEPS 18
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.1.1.1 Secondary research 19
2.1.1.2 Key data from secondary sources 19
2.1.1.3 Primary research 20
2.1.1.4 Key data from primary sources 21
2.1.1.5 Key Industry Insights 22
2.2 MARKET SIZE ESTIMATION METHODOLOGY 22
2.3 RESEARCH DESIGN 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
3.1 INTRODUCTION 27
3.2 CONCLUSION 31
4 PREMIUM INSIGHTS 32
4.1 3D BIOPRINTING: MARKET OVERVIEW 32
4.2 GEOGRAPHIC ANALYSIS: 3D BIOPRINTING MARKET, BY TECHNOLOGY (2016) 33
4.3 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2016 VS. 2021 (USD MILLION) 33
4.4 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 34
4.5 GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Growing demand for organ transplantation 37
5.2.1.2 Rise in public and private funding to support 3D bioprinting research activities 37
5.2.1.3 Increasing use of 3D bioprinting in the drug discovery process 38
5.2.1.4 Growing focus of market players on 3D bioprinting 38
5.2.2 RESTRAINTS 39
5.2.2.1 Lack of regulatory guidelines governing 3D bioprinting 39
5.2.2.2 Dearth of trained professionals 39
5.2.3 OPPORTUNITIES 40
5.2.3.1 Increasing stem cell research 40
5.2.3.2 Growing awareness related to 3D bioprinting 41
5.2.3.3 Rising adoption of 3D bioprinting in the cosmetic industry 41
5.2.4 CHALLENGES 42
5.2.4.1 Socio-ethical concerns related to the use of 3D bioprinted products 42
5.2.4.2 Limitations of biomaterial-based products 42
5.2.4.3 Lack of complete automation 42
6 INDUSTRY INSIGHTS 43
6.1 INTRODUCTION 43
6.2 3D BIOPRINTING APPROACHES 43
6.2.1 BIOMIMICRY 43
6.2.2 AUTONOMOUS SELF-ASSEMBLY 43
6.2.3 MINI-TISSUE BUILDING BLOCKS 43
6.3 3D BIOPRINTING PATENT LANDSCAPE 44
6.4 INDUSTRY TRENDS 45
6.4.1 FUNDING AND INVESTMENTS 45
6.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 45
6.4.3 CONFERENCES AND SYMPOSIUMS 46
7 3D BIOPRINTING MARKET, BY TECHNOLOGY 47
7.1 INTRODUCTION 48
7.2 MAGNETIC 3D BIOPRINTING 49
7.3 LASER-ASSISTED BIOPRINTING 50
7.4 INKJET 3D BIOPRINTING 52
7.5 MICROEXTRUSION BIOPRINTING 54
8 3D BIOPRINTING MARKET, BY MATERIAL 56
8.1 INTRODUCTION 57
8.2 HYDROGELS 58
8.3 EXTRACELLULAR MATRICES 59
8.4 LIVING CELLS 61
8.5 OTHER BIOMATERIALS 62
?
9 3D BIOPRINTING MARKET, BY APPLICATION 64
9.1 INTRODUCTION 65
9.2 CLINICAL APPLICATIONS 66
9.2.1 SKIN 68
9.2.2 BONE & CARTILAGE 69
9.2.3 BLOOD VESSELS 69
9.3 RESEARCH APPLICATIONS 70
9.3.1 DRUG RESEARCH 72
9.3.2 REGENERATIVE MEDICINE 73
9.3.3 3D CELL CULTURE 73
10 3D BIOPRINTING MARKET, BY REGION 75
10.1 INTRODUCTION 76
10.2 NORTH AMERICA 78
10.2.1 U.S. 80
10.2.2 CANADA 83
10.3 EUROPE 85
10.3.1 GERMANY 87
10.3.2 FRANCE 89
10.3.3 U.K. 91
10.3.4 REST OF EUROPE (ROE) 93
10.4 ASIA-PACIFIC 95
10.4.1 JAPAN 97
10.4.2 CHINA 99
10.4.3 INDIA 101
10.4.4 REST OF ASIA-PACIFIC 103
10.5 REST OF THE WORLD (ROW) 105
11 COMPETITIVE LANDSCAPE 107
11.1 OVERVIEW 107
11.2 MARKET RANKING ANALYSIS 108
11.3 COMPETITIVE SITUATION AND TRENDS 109
11.3.1 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 109
11.3.2 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION 110
11.3.3 PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS 111
11.3.4 FUNDING 112
11.3.5 OTHER STRATEGIES 113
?
12 COMPANY PROFILES 114
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 114
12.2 ORGANOVO HOLDINGS, INC. 115
12.3 ENVISIONTEC GMBH 119
12.4 NANO3D BIOSCIENCES, INC. 121
12.5 CYFUSE BIOMEDICAL K.K. 124
12.6 REGENHU LTD. 126
12.7 ASPECT BIOSYSTEMS LTD. 127
12.8 BIOBOTS 128
12.9 CELLINK 129
12.10 GESIM 130
12.11 POIETIS 131
12.12 REGENOVO BIOTECHNOLOGY CO., LTD. 133
12.13 3DYNAMIC SYSTEMS LTD. 134

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 135
13.1 DISCUSSION GUIDE 135
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
13.4 AVAILABLE CUSTOMIZATIONS 141
13.5 RELATED REPORTS 142
13.6 AUTHOR DETAILS 143